FMC Q1 revenue falls 4% to $759 M, EBITDA down 40%
FMC reported Q1 2026 revenue of $759 million, down 4% year-over-year, with adjusted EBITDA of $72 million, 40% lower and a GAAP net loss of $281 million. It reaffirmed 2026 guidance targeting revenue ex-India of $3.60–3.80 billion, adjusted EBITDA of $670–730 million and free cash flow of -$65 million to $65 million.
1. Q1 Financial Results
FMC posted first-quarter revenue of $759 million, down 4% year-over-year, and adjusted EBITDA of $72 million, a 40% decline versus Q1 2025. GAAP net loss widened by $266 million to $281 million, with adjusted loss per share of $0.23, 41 cents lower than last year.
2. Operational and Cost Drivers
Price declined 6% driven by lower diamide partner pricing and competitive legacy product markets, while volume rose 2% Led by EMEA and North America. Foreign currency aided by 5%, but raw material costs, tariffs, higher restructuring and interest expenses weighed on profitability.
3. Full-Year Guidance and Strategy
FMC reaffirmed 2026 revenue ex-India of $3.60–3.80 billion, adjusted EBITDA of $670–730 million, EPS of $1.63–1.89 and free cash flow between -$65 million and $65 million. The company is pursuing $1 billion debt reduction, enhancing portfolio competitiveness, accelerating new active ingredient growth and evaluating strategic alternatives.